Correlation Between Celebrus Technologies and HCA Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Celebrus Technologies and HCA Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Celebrus Technologies and HCA Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Celebrus Technologies plc and HCA Healthcare, you can compare the effects of market volatilities on Celebrus Technologies and HCA Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Celebrus Technologies with a short position of HCA Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Celebrus Technologies and HCA Healthcare.

Diversification Opportunities for Celebrus Technologies and HCA Healthcare

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Celebrus and HCA is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Celebrus Technologies plc and HCA Healthcare in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HCA Healthcare and Celebrus Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Celebrus Technologies plc are associated (or correlated) with HCA Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HCA Healthcare has no effect on the direction of Celebrus Technologies i.e., Celebrus Technologies and HCA Healthcare go up and down completely randomly.

Pair Corralation between Celebrus Technologies and HCA Healthcare

Assuming the 90 days trading horizon Celebrus Technologies plc is expected to generate 1.89 times more return on investment than HCA Healthcare. However, Celebrus Technologies is 1.89 times more volatile than HCA Healthcare. It trades about 0.26 of its potential returns per unit of risk. HCA Healthcare is currently generating about -0.27 per unit of risk. If you would invest  26,000  in Celebrus Technologies plc on August 30, 2024 and sell it today you would earn a total of  4,250  from holding Celebrus Technologies plc or generate 16.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Celebrus Technologies plc  vs.  HCA Healthcare

 Performance 
       Timeline  
Celebrus Technologies plc 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Celebrus Technologies plc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Celebrus Technologies may actually be approaching a critical reversion point that can send shares even higher in December 2024.
HCA Healthcare 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HCA Healthcare has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Celebrus Technologies and HCA Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Celebrus Technologies and HCA Healthcare

The main advantage of trading using opposite Celebrus Technologies and HCA Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Celebrus Technologies position performs unexpectedly, HCA Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HCA Healthcare will offset losses from the drop in HCA Healthcare's long position.
The idea behind Celebrus Technologies plc and HCA Healthcare pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges